课题基金 / 基金详情

Inhibition of superantigen-induced apoptosis by LPS

Inhibition of superantigen-induced apoptosis by LPS
LPS 抑制超抗原诱导的细胞凋亡
批准号:
12671759
负责人:
RIKIISHI Hidemi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

RIKIISHI Hidemi的其他基金

相似基金

相关文献

中文摘要
翻译
对细菌超抗原引发的事件的研究为深入了解微生物和免疫系统之间的持续斗争提供了丰富的见解。本研究探讨了葡萄球菌肠毒素B(SEB)诱导单核细胞凋亡的机制,以及CD80~+单核细胞抗凋亡作用的一些证据。预先给予有效的NF-κB抑制剂吡咯烷二硫代氨基甲酸酯(PDTC)后,单核细胞产生的γ-和干扰素-CD802的百分率显著降低。单核细胞表达组成性的NF-κB结合活性,SEB和干扰素-γ可进一步激活NF-κB,但可被PDTC抑制。加入SEB可促进单核细胞的凋亡。SEB刺激后,sCD95配体(SCD95L)水平升高,而干扰素-γ刺激后sCD95L水平无明显变化。结果表明,SEB可诱导caspase-3和-8的激活,用广谱caspase抑制剂z-VAD-fmk处理可阻止24 h后CD80~+单核细胞的凋亡,CD80~+单核细胞对凋亡敏感,经z-VAD-fmk处理后CD80~+单核细胞存活,CD80~+单核细胞百分率降低。在干扰素-γ组中,PDTC取消了抗细胞凋亡的功能。因此,我们的结果表明,SEB的刺激既包括通过干扰素-κB激活的NF-γ的抗凋亡作用,也包括通过SEB释放的sCD95L的促凋亡作用,并且由NF-κB驱动的CD80允许单核细胞参与不同的生存计划和大量的T细胞激活。
英文摘要
Studies of the events triggered by bacterial superantigens provide rich insight into the constant battle between microbes and the immune system. In this study, we demonstrated a mechanism of apoptosis induced by staphylococcal enterotoxin B (SEB) in monocytes and some evidence for the anti-apoptotic function in CD80^+ monocytes. Pretreatment with pyrrolidine dithiocarbamate (PDTC), a potent inhibitor of NF-κB, resulted in significant reduction of the percentages of SEB-and IFN-γ (produced by SEB)-induced CD80^+ monocytes. Monocytes expressed constitutive NF-κB binding activity, and SEB and IFN-γ further activated NF-κB, which was inhibited by pretreatment with PDTC. Apoptosis of monocytes was enhanced by the addition of SEB. Increases in soluble CD95 ligand (sCD95L) levels were observed following stimulation with SEB, but not IFN-γ. Our results demonstrated that SEB treatment induced the activation of caspase-3 and -8, and pretreatment with z-VAD-fmk, a broad-spectrum inhibitor of caspases, prevented the induction of apoptosis at 24 h. CD80^- monocytes were sensitive to apoptosis, and survival of CD80^- monocytes from apoptosis by treating with z-VAD-fmk resulted in reduction of the percentages of CD80^+ monocytes. PDTC abolished anti-apoptotic function in those treated with IFN-γ. Thus, our results indicated that SEB stimulation includes both anti-apoptotic action through NF-κB activation by IFN-γ and pro-apoptotic action through sCD95L released by SEB, and that CD80 driven by NF-κB allows monocytes to participate in distinct survival programs and massive T-cell activation.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
S. Sugawara: "Monocytic cell activation by nonendotoxic glycoprotein from P. intermedia ATCC 25611 is mediated by TLR2"Infection and Immunity. 69 (8). 4951-4957 (2001)
S. Sukawara:“来自 P. intermedia ATCC 25611 的非内毒性糖蛋白的单核细胞激活是由 TLR2 介导的”感染和免疫。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Sugawara: "Monocytic cell activation by nonendotoxic glycoprotein from P.intermedia ATCC 25611 is mediated by TLR2"Infection and Immunity. 69(8). 4951-4957 (2001)
S.Sukawara:“来自 P.intermedia ATCC 25611 的非内毒性糖蛋白的单核细胞激活是由 TLR2 介导的”感染和免疫。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Takahashi: "Effects of superantigen and lipopolysaccharide on induction of CD80 through apoptosis of human monocytes"Infection and Immunity. (発表予定). (2001)
M. Takahashi:“超抗原和脂多糖对通过人类单核细胞凋亡诱导 CD80 的影响”《感染与免疫》(即将出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Sugawara: "Monocytic cell activation by nonendotoxic glycoprotein from P. intermedia ATCC 25611 is mediated by TLR2"Infection and Immunity. 69(8). 4951-4957 (2001)
S.Sukawara:“来自 P. intermedia ATCC 25611 的非内毒性糖蛋白的单核细胞激活是由 TLR2 介导的”感染和免疫。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    Mechanisms of Taxotere-induced apoptosis in or a squamous cell carcinoma.
    • 批准号:
      16390577
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.66万
    • 财政年份:
      2004
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    Selective apoptosis during treatment with superantigen and lipopolysaccharide
    • 批准号:
      14571726
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.79万
    • 财政年份:
      2002
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    The etiological significance of superantigen in periodontal disease and its possible role
    • 批准号:
      10671695
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1998
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    Induction of cytokines by oral bacterial stimulation and its arthropathic properties
    • 批准号:
      02670824
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1990
    • 负责人:
      RIKIISHI Hidemi
    • 依托单位:
    国内基金
    海外基金
    基于肠道菌群探讨健脾化痰方通过调节LPS/NF-κB信号通路改善多囊卵巢综合征的机制研究
    • 批准号:
      2026JJ80146
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      余曦明
    • 依托单位:
    基于肠道微生态的他莫昔芬-LPS-OTUD6A-HDAC3轴诱导乳腺癌内分泌治疗耐药的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      祝琦
    • 依托单位:
    基于肠道菌群介导的LPS/TLR4/NF-κB信号通路探讨针灸对脑缺血再灌注损伤大鼠的抑炎作用机制